Predict your next investment

Venture Capital
FINANCIAL | Investment Firms & Funds
radiusventures.com

See what CB Insights has to offer

Investments

82

Portfolio Exits

30

Funds

4

About Radius Ventures

Radius Ventures is a venture capital firm that invests in leading-edge, growth equity and expansion-stage health and life sciences companies. The firm is led by a seasoned group of investment professionals with collective experience across all major sectors of the industry, including medical devices, diagnostics, biopharmaceuticals, life science tools, healthcare services and healthcare information technology. Radius takes a hands-on approach with each portfolio company by providing intellectual capital, strategic guidance and access to key industry relationships that ultimately increase the odds of success.

Radius Ventures Headquarter Location

250 Park Avenue Suite 1102

New York, New York, 10177,

United States

212-897-7778

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Radius Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Radius Ventures in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Radius Ventures Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Radius Ventures Rank

Latest Radius Ventures News

EndoGastric Solutions raises $30.5M to commercialize acid reflux treatment

Jul 11, 2018

News Brief: EndoGastric Solutions , a Seattle area biotechnology company, has raised $30.5 million to scale its commercial efforts. Existing investors Advanced Technology Ventures (ATV), Canaan Partners, Canepa Healthcare, Chicago Growth Partners, CRG, Radius Ventures and Sightline Partners took part in the round, along with a number of unnamed new investors. The company — led by former Given Imaging and Abbot Laboratories executive Skip Baldino,  — said in a statement that the cash will support wider commercialization of its treatment for chronic acid reflux, which is already on the market. “This round of funding will enable EGS to continue to expand commercial operations and provide the millions of patients suffering from GERD access to the TIF procedure,” said Baldino in a release . GERD, also known as gastroesophageal reflux disease, is the most common gastrointestinal-related diagnosis, with acid reflux impacting more than 80 million Americans at least once a month, according to estimates. Clare McGrane is a GeekWire reporter who covers life sciences, biotechnology and general assignment technology stories, in addition to producing the GeekWire radio show and podcast. A graduate of the University of Washington, she is passionate about nonfiction storytelling, particularly stories about how science impacts our daily lives. Reach her at clare@geekwire.com and follow her @claremcgrane .

Radius Ventures Investments

82 Investments

Radius Ventures has made 82 investments. Their latest investment was in Amylyx Pharmaceuticals as part of their Series B on July 7, 2020.

CBI Logo

Radius Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/1/2020

Series B

Amylyx Pharmaceuticals

$30M

No

Morningside Technology Ventures, and Undisclosed Investors

6

8/22/2016

Series A

Amylyx Pharmaceuticals

$5M

Yes

ALS Investment Fund, Henri Termeer, and Morningside Technology Ventures

11

5/26/2015

Series H

EndoGastric Solutions

$50M

No

2

3/3/2015

Series C

Subscribe to see more

$99M

Subscribe to see more

10

8/19/2014

Series E

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/1/2020

8/22/2016

5/26/2015

3/3/2015

8/19/2014

Round

Series B

Series A

Series H

Series C

Series E

Company

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals

EndoGastric Solutions

Subscribe to see more

Subscribe to see more

Amount

$30M

$5M

$50M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Morningside Technology Ventures, and Undisclosed Investors

ALS Investment Fund, Henri Termeer, and Morningside Technology Ventures

Sources

6

11

2

10

10

Radius Ventures Portfolio Exits

30 Portfolio Exits

Radius Ventures has 30 portfolio exits. Their latest portfolio exit was NuGEN Technologies on August 16, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/16/2018

Acquired

$991

Tecan

3

11/6/2017

Reverse Merger

Cempra Pharmaceuticals

5

8/21/2017

Acq - Fin

Cagan McAfee Capital Partners, and Myles Sherman

1

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

8/16/2018

11/6/2017

8/21/2017

00/00/0000

00/00/0000

Exit

Acquired

Reverse Merger

Acq - Fin

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

Acquirer

Tecan

Cempra Pharmaceuticals

Cagan McAfee Capital Partners, and Myles Sherman

Subscribe to see more

Subscribe to see more

Sources

3

5

1

10

10

Radius Ventures Fund History

4 Fund Histories

Radius Ventures has 4 funds, including Radius Venture Partners III QP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/17/2007

Radius Venture Partners III QP

$14.25M

1

1/10/2007

Radius Venture Partners III

Subscribe to see more

$99M

10

9/24/2002

Radius Venture Partners II LP

Subscribe to see more

$99M

10

7/31/1997

Radius Venture Partners I LP

Subscribe to see more

$99M

10

Closing Date

12/17/2007

1/10/2007

9/24/2002

7/31/1997

Fund

Radius Venture Partners III QP

Radius Venture Partners III

Radius Venture Partners II LP

Radius Venture Partners I LP

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$14.25M

$99M

$99M

$99M

Sources

1

10

10

10

Radius Ventures Team

1 Team Member

Radius Ventures has 1 team member, including current Founder, Managing Partner, Jordan S. Davis.

Name

Work History

Title

Status

Jordan S. Davis

Founder, Managing Partner

Current

Name

Jordan S. Davis

Work History

Title

Founder, Managing Partner

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.